Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04936009

Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

Noninvasive Brain Stimulation to Treat Core Social Deficits in Autism Spectrum Disorder

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This is a randomized interventional study designed to evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS) on neural and behavioral facets of social cognition in adults with autism spectrum disorder (ASD).

Detailed description

The primary objective of this study is to determine whether rTMS increases the brain response to faces in a population of adults with ASD. This study will assess critical aspects of social cognition using the electroencephalogram (EEG), event-related potentials (ERPS), and eye-tracking (ET) prior to and following a single rTMS session (or Sham) to provide preliminary insight into the potential of rTMS as a tool to modify social brain function in this population. Participant visits will include a baseline assessment of neuropsychological, cognitive and behavioral function, and a pre and post TMS session with EEG (electroencephalogram) and eye-tracking to measure neural and visual attentional social response. Two study visits will be scheduled for each participant lasting approximately 4-5hrs total.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTranscranial Magnetic Stimulation (TMS)Subjects will receive both active and sham TMS in a randomized crossover assignment involving two study sessions

Timeline

Start date
2022-03-17
Primary completion
2026-12-31
Completion
2027-07-01
First posted
2021-06-23
Last updated
2026-02-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04936009. Inclusion in this directory is not an endorsement.